Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
64
days
Cost-effectiveness of nicotine metabolite ratio-guided smoking cessation therapy in China: a hybrid decision-analytic modeling study based on real-world data
Authors
Anqi Cheng; Min Wang; Yingman Gao; Tingfen Ji; Xuejun Hu; Xue Yu; Yong Qi; Wenli Chen; Suqin Xu; Zhao Liu; Xinmei Zhou; Dan Xiao; Chen WangShow moreShow less
Affiliations
1. Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital; 2. WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; 3. National Center for Respiratory Medicine; 4. State Key Laboratory of Respiratory Health and Multimorbidity; 5. National Clinical Research Center for Respiratory Diseases; 6. China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College; 7. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College; 8. Capital Medical University China-Japan Friendship School of Clinical Medicine; 9. Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University; 10. Department of Respiratory and Critical Care, Tengzhou Central People’s Hospital; 11. Department of Pulmonary and Critical Care Medicine, Henan Provincial People’s Hospital; 12. Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Chengde Medical College; 13. Department of Pulmonary and Critical Care Medicine, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology; 14. Peking Union Medical College, Chinese Academy of Medical SciencesShow moreShow less
69
days
Costs and healthcare resource utilization after COVID-19 hospitalization among US Medicare patients: a retrospective claims analysis
Authors
Alon Yehoshua; Rachel M. Black; Anan Zhou; Michelle A. Silver; Yu Han; Santiago M. C. Lopez; Benjamin Yarnoff; Rajeev M. Nepal; Maria M. Fernandez; Mohammad Ashraf Chaudhary; Tara AhiShow moreShow less
Affiliations
1. Pfizer Inc; 2. AESARA Inc; 3. Genesis Research Group; 4. Thermo Fisher ScientificShow moreShow less
105
days
Cell and gene therapies in managed care: US payer insights on coverage and financial risk
Authors
Elias C. Pittos; Joe DePintoShow moreShow less
Affiliations
1. McKessonShow moreShow less
48
days
The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study
Authors
Moritz Wick; Oliver Damm; Rolf Kramer; Mathieu Bangert; Jessica Baehre; Frank Eberhardt; Grit Barten-Neiner; David Twardella; Mareike Meier-Maiwald; Christine Happle; Martin WetzkeShow moreShow less
Affiliations
1. Sanofi-Aventis Deutschland GmbH; 2. Sanofi Vaccines; 3. Pediatric Hospital Bult; 4. CAPNETZ Stiftung; 5. Pediatric Pneumology, Allergology, Neonatology, Hannover Medical SchoolShow moreShow less
52
days
Cost-effectiveness of perioperative pembrolizumab plus enfortumab vedotin for cisplatin-ineligible or cisplatin-declining patients with muscle-invasive bladder cancer in the United States
Authors
Daniel Hill-McManus; Yizhen Lai; Arielle G. Bensimon; Joshua Young; Kelly Reeve; Anjela Tzontcheva; Patrick Squires; Haojie Li; Chethan Ramamurthy; Matthew MossanenShow moreShow less
Affiliations
1. MSD (UK) Limited; 2. Merck & Co., Inc; 3. Analysis Group, Inc; 4. MSD; 5. Brigham and Women’s HospitalShow moreShow less
87
days
Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal – A modeling approach
Authors
Filipa de Aragão; Ana Carneiro; Susana Carvalho; Cláudia Claudino; Eduardo Espada; Filipa Moita; Maria João Silva; Sónia Pereira; Alexandra SantosShow moreShow less
Affiliations
1. Public Health Research Centre, NOVA University of Lisbon; 2. Incremental Action Consulting, Lda; 3. Unidade Local de Saúde de São João; 4. Instituto Português de Oncologia de Lisboa; 5. Unidade Local de Saúde de Lisboa Ocidental, EPE, Hospital S. Francisco Xavier; 6. Unidade Local de Saúde Santa Maria, EPE; 7. Instituto Português de Oncologia do Porto; 8. Department of Biology, University of St. Andrews; 9. Gilead Sciences, LdaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days